Dalrada Health Expands Wellness Services to Support Local Athletes and Fans

Dalrada Health’s Sòlas Rejuvenation + Wellness Clinics Partner With San Diego Strike Force IFL and San Diego Loyal Soccer Pro Team to Promote Community Wellness SAN DIEGO–(BUSINESS WIRE)–Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada Corporation,” “Dalrada”), a leading innovator in clean energy, healthcare, technology, and precision manufacturing, announced today the expansion of its wellness services to … [Read more…]

IAVI Announces First Vaccinations at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate

The trial is designed to evaluate the candidate’s safety, tolerability, and immunogenicity NEW YORK–(BUSINESS WIRE)–#OutsmartEpidemics–IAVI, a nonprofit scientific research organization, announces that volunteers at the PREVAIL clinical trial site at Redemption Hospital (RH1) in Monrovia, Liberia, have been vaccinated with IAVI’s novel vaccine candidate against Lassa fever virus (LASV) in a Phase I clinical trial, … [Read more…]

Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced that the Company will present and conduct 1-on-1 meetings with investors at the 2022 Wells Fargo Healthcare Conference and H.C. Wainwright 24th Annual Global Investment Conference. 2022 Wells Fargo … [Read more…]

Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference

NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences, the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) products and technologies to localize testing and reduce time to treatment initiation and overall testing costs, today announced that Randy Pritchard, Chief Executive Officer, and Vincent Ricci, Chief Financial Officer, will participate in investor meetings at the 2022 Wells … [Read more…]

AlloVir to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

WALTHAM, Mass.–(BUSINESS WIRE)–AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference in New York on Wednesday, September 14, 2022, at 12:20 p.m. ET. A live webcast and archived replay … [Read more…]

AVROBIO to Participate in Four Upcoming Investor Conferences in September

CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in four upcoming investor conferences: Citi’s 17th Annual BioPharma Conference Dates: Tuesday, Sept. 6, 2022 – Thursday, Sept. 8, 2022 … [Read more…]

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc., formerly Second Sight Medical, Inc., (NASDAQ: VANI) (the “Company” or “Vivani”) announced that trading of the Company’s common stock on The Nasdaq Capital Market under the symbol “VANI” will commence today. Vivani is the combination of Nano Precision Medical, Inc. (“NPM”) and Second Sight Medical Products, Inc. Closing of the … [Read more…]

Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global DNA Vaccines Market (2022-2027) by Product Type, Type, End-User Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global DNA Vaccines Market is estimated to be USD 477.65 Mn in 2022 and is projected to reach USD 646.47 Mn by 2027, growing … [Read more…]

Europe Antibody Drug Conjugates Market Report 2022: Rising Investments in Research and Development Activities to Develop Novel Therapeutic Drugs Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Europe Antibody Drug Conjugates Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. Major factors that are contributing to the growth of the market include the rising prevalence of cancer across European countries, the increasing geriatric population, and rising investments in research and development activities to develop novel … [Read more…]

Africa Non-Hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Africa Non-Hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering. The country research report on Africa non-Hodgkin lymphoma treatment market is a customer intelligence and competitive study of the Africa market. Moreover, the report provides deep insights into demand forecasts, market … [Read more…]